Takeda and Affymax provide update for Hematide in chemotherapy-induced anemia (News-Medical-Net)

Takeda Pharmaceutical Company Limited and Affymax, Inc. today announced their agreement to suspend co-development of Hematide to treat chemotherapy-induced anemia and to focus all development efforts for Hematide on the treatment of chronic kidney disease related anemia.

Salon Owner Gives Cancer Patients Confidence (KDKA Pittsburgh)

There are many trials and tribulations that come when women find out they have breast cancer, but one of the things women fear most is losing their hair during chemotherapy treatments. Now, one Manhattan salon is helping cancer patients rebuild their self-confidence.

Protein linked to chemo-drug resistance (UPI)

SAN DIEGO, Aug. 28 (UPI) -- U.S. researchers say they have linked a genetic variant of a protein to resistance to the chemotherapy drug cisplatin.

Start Of Prolarix? Phase 2 Study In Liver Cancer (Medical News Today)

Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces the initiation of a phase 2a proof-of-concept study of Prolarix?, a targeted prodrug chemotherapy being developed for the treatment of primary liver cancer (hepatocellular carcinoma or "HCC").

ImClone updates data from lung cancer trial (Reuters via Yahoo! News)

ImClone Systems Inc said on Friday that a trial of its cancer drug Erbitux did not significantly improve overall survival in a trial of patients with the most common form of lung cancer.

Combination Therapy Helps to Combat Myeloma (HealthDay via Yahoo! News)

WEDNESDAY, Aug. 27 (HealthDay News) -- Patients with multiple myeloma who could not tolerate high dose chemotherapy lived longer and better by adding the drug Velcade to standard treatment, a new study found.

Health Highlights: Aug. 29, 2008 (HealthDay via Yahoo! News)

Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

Variation of normal protein could be key to resistance to common cancer drug (EurekAlert!)

( University of California - San Diego ) Researchers at the Moores Cancer Center at the University of California, San Diego, in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the ...

US FDA approves Aloxi caps for chemotherapy-induced nausea & vomiting (PharmaBiz)

Eisai Corporation of North America and its partner Helsinn Healthcare SA announced that the US Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi (palonosetron hydrochloride) for the prevention of chemotherapy-induced nausea and vomiting (CINV).

Combination Therapy Helps to Combat Myeloma (ABC 7 El Paso)

By Steven Reinberg , HealthDay Reporter WEDNESDAY, Aug. 27 (HealthDay News) -- Patients with multiple myeloma who could not tolerate high dose chemotherapy lived...

Cytokinetics Announces Clinical Trials Data Relating to Ispi...

SOUTH SAN FRANCISCO, CA, August 29 / MARKET WIRE/ -- Cytokinetics, Incorporated announced today that data from an ongoing Phase I/II clinical trial of ispinesib are scheduled to be presented as a poster ...

Lucas Learns To Live Again

Lucas Arnold Ker has endured enough tragedy to last a lifetime. But after fearing that all might be lost, the Argentine has bravely breathed renewed purpose into his life and career.

Affymax, Inc. to Stop Trial for Chemotherapy-Induced Anemia

OSAKA, Japan & PALO ALTO, Calif.-- --Takeda Pharmaceutical Company Limited and Affymax, Inc.

New Therapies Increasingly Being Used To Treat Liver Cancer

Main Category: Liver Disease / Hepatitis Also Included In: Cancer / Oncology Article Date: 29 Aug 2008 - 4:00 PDT According to Millennium Research Group's US Markets for Transcatheter Embolization and Occlusion ...

Cytokinetics, Inc.: Cytokinetics Announces Clinical Trials Data...

Additional Results From Ongoing Phase I/II Clinical Trial in Patients With Locally Advanced or Metastatic Breast Cancer Highlighted Links CYTK Website SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated ...

Blood drives to benefit Summer Evans set for Sept. 9, 10

Blood drives to help Summer Evans are set for Sept. 9 at Boley Featherston Insurance, 900 8th St., Suite 510, and Sept.

Winning the Fight and Achieving Survivorship

Published Aug. 28, 2008 at 9:09 p.m. Tags: Cancer Survivor , Fighting Cancer , Eating Healthy , Susan G Komen Here is something I have been ponderinghow and when do you achieve survivor status? After months of ...

New CRMC lobby open soon

The community will get a sneak peak at the new six-story patient tower at Cookeville Regional Medical Center when the lobby is opened to the public beginning Sept.

Teen Crusade fights cancer

While the young women who gather in Jennifer Matsui s Torrance living room have time for small talk, their main goal is to fight pediatric cancer.

Neutering more than population control

Several times in the past couple of months, I have had to do what no doctor looks forward to - deliver the diagnosis of cancer.